These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4595062)
81. Rhythms in bone marrow cell proliferation: how to apply to the chronotherapy of cancer? Haus E; Nicolau GY Chronobiol Int; 1992 Oct; 9(5):393-8. PubMed ID: 1394611 [No Abstract] [Full Text] [Related]
82. How does leukemia invade the central nervous system? Pochedly C Postgrad Med; 1976 Jan; 59(1):101-5. PubMed ID: 1246530 [TBL] [Abstract][Full Text] [Related]
83. Cytology and cytochemistry of the leukemia cell. Beckmann H; Neth R; Gaedicke G; Landbeck G; Schöch G; Wiegers U; Winkler K Hamatol Bluttransfus; 1974; 14():26-35. PubMed ID: 4141328 [No Abstract] [Full Text] [Related]
84. Control of mitosis in rabbit Vx2 epidermal tumours by means of the epidermal chalone. Bullough WS; Laurence EB Eur J Cancer (1965); 1968 Dec; 4(6):587-94. PubMed ID: 5717956 [No Abstract] [Full Text] [Related]
85. Control of DNA duplication in rat chloroleukaemia by means of the granulocytic chalone. Rytömaa T; Kiviniemi K Eur J Cancer (1965); 1968 Dec; 4(6):595-606. PubMed ID: 5252065 [No Abstract] [Full Text] [Related]
86. [Proliferative ability of cell populations and treatment of neoplasms]. Rajewsky MF Nowotwory; 1976; 26(3):153-62. PubMed ID: 980800 [No Abstract] [Full Text] [Related]
87. In vitro assays in preclinical antineoplastic drug screening. Weisenthal LM Semin Oncol; 1981 Dec; 8(4):362-76. PubMed ID: 7034203 [No Abstract] [Full Text] [Related]
88. Mitogenesis and the search for new targets for anticancer drug design. Reeve JG Tumour Biol; 1991; 12(1):1-8. PubMed ID: 1996401 [TBL] [Abstract][Full Text] [Related]
89. [Chemotherapy of malignant blood diseases with substances inhibiting mitosis]. MARINONE G Rev Hematol; 1953; 8(4):438-61. PubMed ID: 13167792 [No Abstract] [Full Text] [Related]
90. [Research on a little known element of hematopoiesis: duration of mitoses of myeloid cells]. JOURNOUD R Sang; 1953; 24(4):355-63. PubMed ID: 13101589 [No Abstract] [Full Text] [Related]
91. Contradictory Relationships between Cancer and Normal Cells and Implications for Anti-cancer Therapy. Gou XC; Kong D; Tang X Asian Pac J Cancer Prev; 2015; 16(13):5143-7. PubMed ID: 26225643 [TBL] [Abstract][Full Text] [Related]
92. Disordered leucocyte proliferation in leukaemia. Stuart J Br Med J; 1972 Apr; 2(5806):152-5. PubMed ID: 5017308 [No Abstract] [Full Text] [Related]
93. Nitroheterocycle reduction as a paradigm for intramolecular catalysis of drug delivery to hypoxic cells. Firestone A; Mulcahy RT; Borch RF J Med Chem; 1991 Sep; 34(9):2933-5. PubMed ID: 1895311 [No Abstract] [Full Text] [Related]
95. Human trials of new cancer therapy begin. Marx JL Science; 1987 May; 236(4803):778-9. PubMed ID: 3554509 [No Abstract] [Full Text] [Related]
96. [Selected problems concerning the treatment of proliferative syndromes of the hemopoietic system]. Polubiec A Pol Arch Med Wewn; 1981 Apr; 65(4):257-65. PubMed ID: 7267377 [No Abstract] [Full Text] [Related]
97. Proceedings: Role of target cells in determining leukaemic characteristics. Lajtha LG Br J Cancer; 1975 Aug; 32(2):284-5. PubMed ID: 1212408 [No Abstract] [Full Text] [Related]
99. Regulation of cell-surface structures in malignancy, differentiation and proliferation. Greaves MF Biochem Soc Trans; 1984 Jun; 12(3):532-3. PubMed ID: 6734912 [No Abstract] [Full Text] [Related]
100. [Treatment of neoplasms of the hematopoietic system based on some principles of cytokinetics]. Traczyk Z Acta Haematol Pol; 1974; 5(1):85-90. PubMed ID: 4595062 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]